AllAfrica on MSN
Two Drugmakers Will Sell The 6-monthly Anti-HIV Jab for The Price of The Daily HIV Prevention Pill
Hetero and Dr Reddy’s — will be funded by the Gates Foundation and Unitaid, respectively, to produce and sell the twice-a-year anti-HIV shot, lenacapavir, for $40 (around R692) per person per ...
A long-acting HIV jab promises near-perfect protection at just $40 a year, but 115 nations must wait for India's approval of ...
Gilead drug deal opens door for $40-a-year generic version of groundbreaking HIV prevention overseas
Gilead's groundbreaking HIV prevention drug will soon be available at a fraction of its U.S. price in over 100 countries, ...
An X-ray crystal structure of MK-8527 triphosphate (TP) bound to the complex of HIV reverse transcriptase and DNA shows the drug candidate’s alkyne extending into a key pocket to the upper left of the ...
SPOKANE, Wash. – A Spokane resident has been sentenced to twenty years in prison and five years of court supervision for his role in a commercial pill operation in Hillyard that had supplies to make ...
Charlie Sheen wasn't expecting to endure a "sixth" stage of grief after receiving his HIV-positive diagnosis in 2011. In his new memoir, "The Book of Sheen," the award-winning actor admitted that ...
Researchers are working on a pill that could allow patients’ brains to recover from a traumatic injury or stroke, defying conventional thinking that the brain cannot regenerate following such a ...
FIRST ON FOX—The Restoration of America Foundation (ROAF) is calling on the Senate Finance Committee to hold Health and Human Services Secretary Robert F. Kennedy Jr. accountable at Thursday’s 10 a.m.
Neurologists are exploring medications that would help the brain recover after a stroke or traumatic injury. Credit...Fabio-Consoli Supported by By Rachel E. Gross The first thing Debra McVean did ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. This edge has propelled Lilly to the forefront, with ...
A new pre-exposure prophylaxis (PrEP) drug has shown promise as a once-monthly oral pill to help prevent HIV. PrEP plays a key part in reducing the number of new HIV infections by stopping the virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results